148 related articles for article (PubMed ID: 26746368)
1. [Squamous cell carcinoma, basaloid squamous cell carcinoma and adenosquamous carcinoma in the lung].
Vignaud JM
Ann Pathol; 2016 Jan; 36(1):15-23. PubMed ID: 26746368
[TBL] [Abstract][Full Text] [Related]
2. [Large cell carcinoma, lymphoepithelioma-like carcinoma, NUT carcinoma].
Copin MC
Ann Pathol; 2016 Jan; 36(1):24-33. PubMed ID: 26739900
[TBL] [Abstract][Full Text] [Related]
3. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic features and genetic profile of the redefined large cell lung carcinoma].
Hou LK; Zhang LP; Zhang W; Huang Y; Wu W; Dong ZW; Wu CY
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):298-302. PubMed ID: 28468033
[No Abstract] [Full Text] [Related]
5. Distinctive association of p16INK4a overexpression with penile intraepithelial neoplasia depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature.
Chaux A; Pfannl R; Lloveras B; Alejo M; Clavero O; Lezcano C; Muñoz N; de Sanjosé S; Bosch X; Hernández-Pérez M; Velazquez EF; Cubilla AL
Am J Surg Pathol; 2010 Mar; 34(3):385-92. PubMed ID: 20139761
[TBL] [Abstract][Full Text] [Related]
6. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
Pelosi G; Fabbri A; Bianchi F; Maisonneuve P; Rossi G; Barbareschi M; Graziano P; Cavazza A; Rekhtman N; Pastorino U; Scanagatta P; Papotti M
J Thorac Oncol; 2012 Feb; 7(2):281-90. PubMed ID: 22071786
[TBL] [Abstract][Full Text] [Related]
7. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?
Vincenten JP; Smit EF; Grünberg K; Postmus PE; Snijders PJ; Witte BI; Heideman DA; Thunnissen E
Lung Cancer; 2015 Jul; 89(1):19-26. PubMed ID: 25982011
[TBL] [Abstract][Full Text] [Related]
8. Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies.
Forest F; Yvorel V; Karpathiou G; Stachowicz ML; Vergnon JM; Fournel P; Tiffet O; Trombert B; Péoc'h M
Hum Pathol; 2016 Mar; 49():99-106. PubMed ID: 26826416
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer.
Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini EM; Guazzi A; Ardizzoni A
J Thorac Oncol; 2011 Mar; 6(3):489-93. PubMed ID: 21258246
[TBL] [Abstract][Full Text] [Related]
10. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.
Kanazawa H; Ebina M; Ino-Oka N; Shimizukawa M; Takahashi T; Fujimura S; Imai T; Nukiwa T
Am J Pathol; 2000 Apr; 156(4):1289-98. PubMed ID: 10751354
[TBL] [Abstract][Full Text] [Related]
11. MUC1 and bcl-2 expression in preinvasive lesions and adenosquamous carcinoma of the lung.
Demirag F; Cakir E; Bayiz H; Eren Yazici U
Acta Chir Belg; 2013; 113(1):19-24. PubMed ID: 23550464
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential serum biomarkers for simultaneously classifying lung adenocarcinoma, squamous cell carcinoma and small cell carcinoma.
Yu J; Du F; Yang L; Chen L; He Y; Geng R; Wu L; Xie B
Cancer Biomark; 2021; 30(3):331-342. PubMed ID: 33361584
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic and treatment pitfalls and guidelines for variants of squamous cell carcinomas of the head and neck: on behalf of the REFCOR].
Thariat J; Hourseau M; Baglin AC; Digue L; Vulquin N; Badoual C; Baujat B; Janot F; Ferrand FR; Barry B
Bull Cancer; 2019 Apr; 106(4):395-403. PubMed ID: 30878134
[TBL] [Abstract][Full Text] [Related]
14. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
15. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
[TBL] [Abstract][Full Text] [Related]
16. p53 protein accumulates frequently in early bronchial neoplasia.
Bennett WP; Colby TV; Travis WD; Borkowski A; Jones RT; Lane DP; Metcalf RA; Samet JM; Takeshima Y; Gu JR
Cancer Res; 1993 Oct; 53(20):4817-22. PubMed ID: 8402667
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
[TBL] [Abstract][Full Text] [Related]
18. Decreased sphingomyelin (t34:1) is a candidate predictor for lung squamous cell carcinoma recurrence after radical surgery: a case-control study.
Takanashi Y; Funai K; Eto F; Mizuno K; Kawase A; Tao H; Kitamoto T; Takahashi Y; Sugimura H; Setou M; Kahyo T; Shiiya N
BMC Cancer; 2021 Nov; 21(1):1232. PubMed ID: 34789180
[TBL] [Abstract][Full Text] [Related]
19. Proposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma.
Weichert W; Kossakowski C; Harms A; Schirmacher P; Muley T; Dienemann H; Warth A
Eur Respir J; 2016 Mar; 47(3):938-46. PubMed ID: 26541540
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.
Lockwood WW; Chari R; Coe BP; Thu KL; Garnis C; Malloff CA; Campbell J; Williams AC; Hwang D; Zhu CQ; Buys TP; Yee J; English JC; Macaulay C; Tsao MS; Gazdar AF; Minna JD; Lam S; Lam WL
PLoS Med; 2010 Jul; 7(7):e1000315. PubMed ID: 20668658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
